Published in Hum Genet on January 23, 2010
A genomic view of mosaicism and human disease. Nat Rev Genet (2013) 2.67
Somatic genome variations in health and disease. Curr Genomics (2010) 1.04
TE-Locate: A Tool to Locate and Group Transposable Element Occurrences Using Paired-End Next-Generation Sequencing Data. Biology (Basel) (2012) 0.90
Pathway-based analysis tools for complex diseases: a review. Genomics Proteomics Bioinformatics (2014) 0.87
Changing genetic paradigms: creating next-generation genetic databases as tools to understand the emerging complexities of genotype/phenotype relationships. Hum Genomics (2014) 0.79
Androgen receptor gene polymorphisms and alterations in prostate cancer: of humanized mice and men. Mol Cell Endocrinol (2011) 0.76
Concise review: carbon nanotechnology: perspectives in stem cell research. Stem Cells Transl Med (2013) 0.75
Initial sequencing and analysis of the human genome. Nature (2001) 212.86
The sequence of the human genome. Science (2001) 101.55
A comprehensive catalogue of somatic mutations from a human cancer genome. Nature (2009) 24.27
A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature (2009) 18.39
Sequence and structural variation in a human genome uncovered by short-read, massively parallel ligation sequencing using two-base encoding. Genome Res (2009) 15.15
Evaluation of next generation sequencing platforms for population targeted sequencing studies. Genome Biol (2009) 9.59
Single-molecule sequencing of an individual human genome. Nat Biotechnol (2009) 8.35
The first Korean genome sequence and analysis: full genome sequencing for a socio-ethnic group. Genome Res (2009) 7.87
Subclonal phylogenetic structures in cancer revealed by ultra-deep sequencing. Proc Natl Acad Sci U S A (2008) 7.22
Characterization of mutation spectra with ultra-deep pyrosequencing: application to HIV-1 drug resistance. Genome Res (2007) 5.95
Costs and benefits of genetic heterogeneity within organisms. J Evol Biol (2004) 5.58
F-SNP: computationally predicted functional SNPs for disease association studies. Nucleic Acids Res (2007) 5.34
Context, tissue plasticity, and cancer: are tumor stem cells also regulated by the microenvironment? Cancer Cell (2005) 3.67
The population dynamics of cancer: a Darwinian perspective. Int J Epidemiol (2006) 3.59
Investigation of heteroplasmy in the human mitochondrial DNA control region: a synthesis of observations from more than 5000 global population samples. J Mol Evol (2009) 3.47
Human cancers express a mutator phenotype. Proc Natl Acad Sci U S A (2006) 3.11
BAK1 gene variation and abdominal aortic aneurysms. Hum Mutat (2009) 2.34
The androgen receptor gene mutations database (ARDB): 2004 update. Hum Mutat (2004) 2.25
Parallel sequencing used in detection of mosaic mutations: comparison with four diagnostic DNA screening techniques. Hum Mutat (2009) 2.19
Cancer: drivers and passengers. Nature (2007) 2.11
Mutational heterogeneity in human cancers: origin and consequences. Annu Rev Pathol (2010) 2.02
The goals of medicine. Towards a unified theory. Health Care Anal (2001) 2.00
Evidence for a repressive function of the long polyglutamine tract in the human androgen receptor: possible pathogenetic relevance for the (CAG)n-expanded neuronopathies. Hum Mol Genet (1995) 1.91
Treatment-dependent androgen receptor mutations in prostate cancer exploit multiple mechanisms to evade therapy. Cancer Res (2009) 1.71
Partial penetrance facilitates developmental evolution in bacteria. Nature (2009) 1.66
Somatic mosaicism and variable expressivity. Trends Genet (2001) 1.64
Evolution in health and medicine Sackler colloquium: Somatic evolutionary genomics: mutations during development cause highly variable genetic mosaicism with risk of cancer and neurodegeneration. Proc Natl Acad Sci U S A (2009) 1.59
Genotype-phenotype databases: challenges and solutions for the post-genomic era. Nat Rev Genet (2009) 1.52
Evolution of intratumoral genetic heterogeneity during colorectal cancer progression. Carcinogenesis (2005) 1.45
Too many mutants with multiple mutations. Crit Rev Biochem Mol Biol (2007) 1.38
Somatic gene mutation and human disease other than cancer. Mutat Res (2003) 1.29
Multiple novel alterations in Kit tyrosine kinase in patients with gastrointestinally pronounced systemic mast cell activation disorder. Scand J Gastroenterol (2007) 1.07
Revertant somatic mosaicism in the Wiskott-Aldrich syndrome. Immunol Res (2009) 1.05
Anatomic distribution and pathologic characterization of small-volume prostate cancer (<0.5 ml) in whole-mount prostatectomy specimens. Mod Pathol (2005) 1.03
Multiple mutations responsible for frequent genetic diseases in isolated populations. Eur J Hum Genet (2007) 1.01
The clinical variability of maternally inherited diabetes and deafness is associated with the degree of heteroplasmy in blood leukocytes. J Clin Endocrinol Metab (2009) 0.91
Somatic mosaicism and cancer: a micro-genetic examination into the role of the androgen receptor gene in prostate cancer. Cancer Res (2005) 0.89
Adaptation of green microalgae to the herbicides simazine and diquat as result of pre-selective mutations. Aquat Toxicol (2009) 0.84
Will knowledge of human genome variation result in changing cancer paradigms? Bioessays (2007) 0.84
Timing matters: error-prone gap filling and translesion synthesis in immunoglobulin gene hypermutation. Philos Trans R Soc Lond B Biol Sci (2009) 0.83
Evolution of highly polymorphic T cell populations in siblings with the Wiskott-Aldrich Syndrome. PLoS One (2008) 0.81
Influence of the tissue microenvironment on Toll-like receptor expression by CD11c+ antigen-presenting cells isolated from mucosal tissues. Clin Vaccine Immunol (2009) 0.81
Androgen receptor CAG repeat length contraction in diseased and non-diseased prostatic tissues. Prostate Cancer Prostatic Dis (2007) 0.78
Much ado about nothing... so far? J Evol Biol (2004) 0.76
Intraorganismal genetic heterogeneity: is it a useful concept? J Evol Biol (2004) 0.75
What is paradominant inheritance? J Med Genet (2009) 0.75
One hundred fifty years without Darwin are enough! Genome Res (2009) 0.75
The androgen receptor gene mutations database (ARDB): 2004 update. Hum Mutat (2004) 2.25
The androgen receptor gene mutations database: 2012 update. Hum Mutat (2012) 1.84
Molecular pathology of the androgen receptor in male (in)fertility. Reprod Biomed Online (2005) 1.16
Estrogen and androgen protection of human neurons against intracellular amyloid beta1-42 toxicity through heat shock protein 70. J Neurosci (2004) 1.06
Mechanisms mediating spinal and bulbar muscular atrophy: investigations into polyglutamine-expanded androgen receptor function and dysfunction. Front Neurol (2013) 1.05
"Hamartoma" of the spleen (splenoma) in children. Pediatr Dev Pathol (2004) 1.02
The use of androgen receptor amino/carboxyl-terminal interaction assays to investigate androgen receptor gene mutations in subjects with varying degrees of androgen insensitivity. J Clin Endocrinol Metab (2003) 0.98
Cancer systems biology in the genome sequencing era: part 1, dissecting and modeling of tumor clones and their networks. Semin Cancer Biol (2013) 0.97
Topotecan is active against Wilms' tumor: results of a multi-institutional phase II study. J Clin Oncol (2007) 0.95
Isolation of human proteasomes and putative proteasome-interacting proteins using a novel affinity chromatography method. Exp Cell Res (2008) 0.91
Cancer systems biology in the genome sequencing era: part 2, evolutionary dynamics of tumor clonal networks and drug resistance. Semin Cancer Biol (2013) 0.91
Underexpression of mineralocorticoid receptor in colorectal carcinomas and association with VEGFR-2 overexpression. J Gastrointest Surg (2007) 0.89
Somatic mosaicism and cancer: a micro-genetic examination into the role of the androgen receptor gene in prostate cancer. Cancer Res (2005) 0.89
Impaired helix 12 dynamics due to proline 892 substitutions in the androgen receptor are associated with complete androgen insensitivity. Hum Mol Genet (2006) 0.86
A functional analysis of disease-associated mutations in the androgen receptor gene. Nucleic Acids Res (2003) 0.85
Will knowledge of human genome variation result in changing cancer paradigms? Bioessays (2007) 0.84
Nuclear receptors and disease: androgen receptor. Essays Biochem (2004) 0.84
Polymorphisms and HNPCC: PMS2-MLH1 protein interactions diminished by single nucleotide polymorphisms. Hum Mutat (2002) 0.82
Transglutaminase potentiates ligand-dependent proteasome dysfunction induced by polyglutamine-expanded androgen receptor. Hum Mol Genet (2003) 0.82
Microsatellite instability in benign and malignant thyroid neoplasms. J Surg Res (2008) 0.80
Shared Decision Making in Total Joint Replacement. JBJS Rev (2014) 0.80
Dynamic rewiring of the androgen receptor protein interaction network correlates with prostate cancer clinical outcomes. Integr Biol (Camb) (2011) 0.80
Changing genetic paradigms: creating next-generation genetic databases as tools to understand the emerging complexities of genotype/phenotype relationships. Hum Genomics (2014) 0.79
Making sense of intratumor genetic heterogeneity: altered frequency of androgen receptor CAG repeat length variants in breast cancer tissues. Hum Mutat (2013) 0.79
An examination of how different mutations at arginine 855 of the androgen receptor result in different androgen insensitivity phenotypes. Mol Endocrinol (2004) 0.78
Bridging structural biology and genetics by computational methods: an investigation into how the R774C mutation in the AR gene can result in complete androgen insensitivity syndrome. Hum Mutat (2003) 0.78
Somatic mosaicism of androgen receptor CAG repeats in colorectal carcinoma epithelial cells from men. J Surg Res (2008) 0.78
An investigation into CAG repeat length variation and N/C terminal interactions in the T877A mutant androgen receptor found in prostate cancer. J Steroid Biochem Mol Biol (2008) 0.77
Handheld impedance biosensor system using engineered proteinaceous receptors. Biomed Microdevices (2010) 0.77
Correction: Engineering Multi-Walled Carbon Nanotube Therapeutic Bionanofluids to Selectively Target Papillary Thyroid Cancer Cells. PLoS One (2016) 0.75
[Polyphenols content and antioxidant capacity in beverages made with panela]. Arch Latinoam Nutr (2012) 0.75
Demonstration of a plasmonic thermocycler for the amplification of human androgen receptor DNA. Analyst (2012) 0.75